Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
第一作者:
M,El Karbane
第一单位:
Research team of pharmaceutical and toxicological analysis, laboratory of pharmacology and toxicology, faculty of medicine and pharmacy, Mohammed V university, Soussi, Rabat, Morocco; Physicochemical service, drugs quality control laboratory, division of drugs and pharmacy, Ministry of Health, Rabat, Morocco.
作者:
医学主题词
丁羟茴香醚(Butylated Hydroxyanisole);色谱法, 高压液相(Chromatography, High Pressure Liquid);药物污染(Drug Contamination);药物稳定性(Drug Stability);羟甲基戊二酰基CoA还原酶抑制剂(Hydroxymethylglutaryl-CoA Reductase Inhibitors);检测限(Limit of Detection);质量控制(Quality Control);参考标准(Reference Standards);结果可重复性(Reproducibility of Results);斯伐他汀(Simvastatin);分光光度法, 紫外线(Spectrophotometry, Ultraviolet);片剂(Tablets)
DOI
10.1016/j.pharma.2014.03.002
PMID
24997886
发布时间
2019-12-10
- 浏览41
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



